Unlocking Myasthenia gravis
av medthority
Episode 25 – Understanding and managing triggers in myasthenia gravis
Om den här podden
Join our host Professor Nils Erik Gilhus, and a panel of experts in myasthenia gravis (MG) as they discuss a range of medical and clinical challenges related to the management of MG.
Coming soon - Professor Maria Teressa Ferretti will be joined by her friend and MG patient Maya Uccheddu, to discuss patient perspective and the burden of this disease.
This content is intended for Healthcare Professionals only. Not intended for US audiences.
Avsnitt
De 20 senaste av 25 avsnitt
- Episode 25 – Understanding and managing triggers in myasthenia gravis · 16 min · Avsnitt 25Episode 25 – Lorenzo Maggi and Nils Erik Gilhus discuss triggers of exacerbations in MG, focusing on how to recognize and manage worsening symptoms in clinical practice. They…
- Episode 24 – Aging in myasthenia gravis: What’s changed? · 16 min · Avsnitt 24Episode 24 – Nils Erik Gilhus and Elena Cortés‑Vicente share their clinical perspective and experience on the evolving landscape of MG in older adults, highlighting the rising…
- Episode 23 – Communication with patients · 17 min · Avsnitt 23Episode 23 – Sophie Lehnerer joins Nils Erik Gilhus to discuss how chat-based digital communication and remote symptom monitoring can support follow-up in MG. They describe how…
- Episode 22 – Myasthenia gravis treatment landscape: What to expect in the future · 17 min · Avsnitt 22Episode 22 – Maria Da Silva Leite and Nils Erik Gilhus examine how MG treatment approaches are evolving, with a focus on antibody-defined subtypes, treatment goals, and long-term…
- Episode 21 – Understanding thymectomy in MG · 20 min · Avsnitt 21Gil Wolfe joins Nils Erik Gilhus to discuss thymectomy in people with MG, with a focus on indications, patient selection, and optimal timing. They reflect on which people with…
- Episode 20 – Understanding patients and the questions they don’t ask · 20 min · Avsnitt 20Episode 20 – John Vissing discusses what patients with MG often leave unsaid in clinic, including why symptoms may not be volunteered without targeted questioning, how patients…
- Episode 19 – MG then and now: How the landscape has changed · 15 min · Avsnitt 19Episode 19 – Henry Kaminski and Nils Erik Gilhus reflect on how MG care has evolved. From the impact of targeted therapies, such as complement and FcRn inhibitors, to…
- Episode 18 – Upcoming changes in MG: AI and technology driving the future · 16 min · Avsnitt 18Episode 18 – Digital innovation is transforming the way we manage MG. Henry Kaminski joins Nils Erik Gilhus to discuss the role of AI, remote monitoring, and patient-driven tools…
- Episode 17 – The urgency of myasthenic crisis · 22 min · Avsnitt 17Episode 17 - Tobias Ruck joins Nils Erik Gilhus to share his experience managing a compelling case involving a patient with recurrent crises and respiratory failure. Together…
- Episode 16 – Life beyond MG · 16 min · Avsnitt 16Episode 16 – Professor Nils Erik Gilhus welcomes Professor Francesco Saccà to discuss quality of life in people with MG, including the outsized impact of unpredictable symptoms…
- Episode 15 – The nature of myasthenia gravis · 16 min · Avsnitt 15Episode 15 – Professor Francesco Saccà joins Professor Nils Erik Gilhus to delve into the pathophysiology of MG, discussing the role of the complement system, what determines…
- Episode 14 – New and improved assays for detecting antibodies · 16 min · Avsnitt 14Episode 14 – Cell-based diagnostic assays now available for MG are more sensitive than previous assays, but “are they as specific?” Professor Nils Erik Gilhus and Dr Gregorio…
- Episode 13 – EAN 2024 special · 18 min · Avsnitt 13Episode 13 – Professor Jan De Bleecker joins Professor Nils Erik Gilhus to reflect on EAN 2024 and discuss key congress highlights, including information on therapeutic advances…
- Episode 12 – Late-onset myasthenia gravis · 18 min · Avsnitt 12Professor Nils Erik Gilhus welcomes Professor Ernestina Santos to discuss late-onset MG, including the definition of late onset versus early onset, diagnostic and treatment…
- Episode 11 – Steroids in myasthenia gravis · 16 min · Avsnitt 11Professor Tarek Sharshar joins Professor Nils Erik Gilhus to discuss the use of steroids in people with MG, including dose recommendations, and treatment in the intensive care…
- Episode 10 – Unmet needs in myasthenia gravis · 16 min · Avsnitt 10Professor Nils Erik Gilhus welcomes Dr Sarah Hoffmann to discuss the challenge of unmet treatment needs in MG, particularly for subgroups under-represented in clinical trials…
- Episode 9 – Pregnancy and myasthenia gravis · 16 min · Avsnitt 9Dr Christiane Schneider-Gold joins Professor Nils Erik Gilhus to discuss pregnancy in people with MG, including special precautions for delivery and the risk of transient…
- Episode 8 – Diagnostic delay in myasthenia gravis · 18 min · Avsnitt 8Professor Benedikt Schoser joins Professor Nils Erik Gilhus to discuss the challenge of diagnostic delay in people with MG covering possible reasons for delays and recommended…
- Episode 7 – Physical exercise in myasthenia gravis · 18 min · Avsnitt 7“It’s a matter of finding the right exercise type, based on the personality.” Professor Anna Rostedt Punga joins Professor Nils Erik Gilhus to discuss the benefits of physical…
- Episode 6 – Autoantibodies as biomarkers · 15 min · Avsnitt 6“Changes in antibody concentrations should influence your therapeutic decision.” Professor Nils Erik Gilhus is joined by Professor Marc De Baets to discuss the importance of…







